TheraRadar

Pharma Intelligence, Simplified

Company Portfolios →

argenx

31 active trials across 7 therapeutic areas

31
Active Trials
3
Phase 1
14
Phase 2
17
Phase 3
7
Therapeutic Areas

Immunology

14 active / 23 total
Rheumatoid Arthritis
8 active 6 Ph3
16 total since 2015
Ankylosing Spondylitis
6 active 5 Ph3
6 total since 2015
Lupus
0 active
1 total since 2015

CNS

8 active / 10 total
Neuropathy
6 active 3 Ph3
8 total since 2015
Multiple Sclerosis
1 active
1 total since 2015
ALS
1 active
1 total since 2015

Rare Disease

5 active / 9 total
Immune Thrombocytopenia
4 active 4 Ph3
8 total since 2015
Spinal Muscular Atrophy
1 active
1 total since 2015

Urology

3 active / 3 total
Erectile Dysfunction
3 active 2 Ph3
3 total since 2015

Cardiovascular

2 active / 2 total
Myocardial Infarction
1 active
1 total since 2015
Atrial Fibrillation
1 active
1 total since 2015

Infectious Disease

0 active / 1 total
COVID-19
0 active
1 total since 2015

Oncology

0 active / 1 total
Solid Tumor (Advanced)
0 active
1 total since 2015

Click an indication to see competitive landscape (all sponsors in that indication).

Data: ClinicalTrials.gov (2015+)